Cargando…
Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19
Autores principales: | Santos, Arnoldo, Martínez-Milla, Juan, Pérez-Calvo, César, Ibáñez, Borja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722669/ https://www.ncbi.nlm.nih.gov/pubmed/34991793 http://dx.doi.org/10.1016/j.jacc.2021.10.030 |
Ejemplares similares
-
Metoprolol in Critically Ill Patients With COVID-19
por: Clemente-Moragón, Agustín, et al.
Publicado: (2021) -
Levels of biological plausibility
por: Love, Bradley C.
Publicado: (2021) -
Neutrophil stunning by metoprolol reduces infarct size
por: García-Prieto, Jaime, et al.
Publicado: (2017) -
Tromboembolia pulmonar en la COVID-19. Cuando nada es lo que parece
por: Ioan, Ana-Maria, et al.
Publicado: (2020) -
Pulmonary embolism in COVID-19. When nothing is what it seems
por: Ioan, Ana-Maria, et al.
Publicado: (2020)